Kangmei Pharma | 600518 - Loan Capital


Kangmei Pharma reported CNY68.57M in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
Akebia Therapeutics USD 24.75M 11.64M Jun/2026
Alaunos Therapeutics USD 4.47M 5.85M Jun/2022
Avita Medical AUD 42.24M 1.25M Dec/2024
Cspc Pharmaceutical CNY 180.69M 21.94M Dec/2025
Dianthus Therapeutics USD 0 0 Dec/2024
Genomma Lab Internacional MXN 2.41B 2.31B Jun/2026
Hypermarcas BRL 7.92B 189.66M Mar/2026
Ionis Pharmaceuticals USD 1.91B 6.62M Jun/2026
IQVIA Holdings USD 13.7B 284M Jun/2026
Jiangsu Hengrui CNY 38.23M 1.13M Jun/2026
Kangmei Pharma CNY 68.57M 9.87M Mar/2026
Moderna USD 597M 6M Jun/2026
Organon & Co USD 8.48B 74M Jun/2026
Revvity USD 2.63B 1.02M Jun/2026
Sh Fosun Pharma CNY 16.31B 359.28M Jun/2026
Tectonic Therapeutic USD 17K 26K Mar/2026
Viatris USD 11.61B 801.1M Jun/2026
Wuxi Apptec CNY 2.19B 370.98M Jun/2026
Xeris Pharmaceuticals USD 188.81M 32.42M Jun/2026
Zz Pientze Pharmaceu CNY 182.29M 4.27M Mar/2026